FEATURED/ARCHIVES (28/03/24)
The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review · April 2021
Articles
International Journal of Environmental Research and Public Health
Sex Differences in Antipsychotic Efficacy and Side Effects in Schizophrenia Spectrum Disorder: Results from the Best Intro Study · August 2021
Articles
NPJ Schizophrenia
Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated with Treatment Response · January 2022
Articles
Nicotine and Tobacco Research
Pharmacogenetic Testing among Patients with Depression in a US Managed Care Population · April 2022
Articles
Clinical and Translational Science
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series · July 2022
Articles
Neuropsychiatric Disease and Treatment
Systematic Reviews and Meta-Analyses of Treatment Interventions for Internet Use Disorders: Critical Analysis of the Methodical Quality According to the PRISMA Guidelines · March 2023
Articles
Journal of Behavioral Addictions
The Prescriber’s Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression · July 2022
Articles
CNS Spectrums
Efficacy of Varenicline in the Treatment of Alcohol Dependence: An Updated Meta-Analysis and Meta-Regression · February 2023
Articles
International Journal of Environmental Research and Public Health
Opioid Agonist Treatment for People Who Are Dependent on Pharmaceutical Opioids · September 2022
Articles
Cochrane Database of Systematic Reviews
The Four-Factor Personality Model and Its Qualitative Correlates among Opioid Agonist Therapy Clients · June 2023
Articles
Frontiers in Psychiatry
Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Handwriting Kinematics in Patients with Schizophrenia Treated with Long-Acting Injectable Atypical Antipsychotics: Results from the ALPINE Study · March 2022
Articles
Schizophrenia Bulletin Open
Buprenorphine/Naloxone Associated with a Reduced Odds of Fentanyl Exposure among a Cohort of People Who Use Drugs in Vancouver, Canada · August 2021
Articles (Manuscripts-Versions)
PubMed Central>Drug and Alcohol Dependence
The Therapeutic Effect of N-Acetylcysteine as an Add-On to Methadone Maintenance Therapy Medication in Outpatients with Substance Use Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial · November 2022
Articles
Brain and Behavior
Clinical, Behavioral, and Neural Measures of Reward Processing Correlate with Escitalopram Response in Depression: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report · April 2020
Articles
NCBI>Neuropsychopharmacology
The Role of Acetylcholinesterase Inhibitors in the Treatment of Prolonged Postelectroconvulsive Therapy Delirium · May 2022
Articles
Case Reports in Psychiatry
Efficacy of D-Cycloserine Augmented Brief Intensive Cognitive-Behavioural Therapy for Paediatric Obsessive-Compulsive Disorder: A Randomised Clinical Trial · January 2022
Articles
Depression and Anxiety
Antipsychotic Treatment Patterns in Refugees and Their Swedish-Born Peers with First-Episode Non-Affective Psychosis: Findings from the REMAIN Study · April 2023
Articles
BJPsych Open
Professional Education to Reduce Provider Stigma Toward Harm Reduction and Pharmacotherapy · July 2021
Articles
Drugs: Education, Prevention and Policy